CompletedNCT03512418
PrEPSteps: A Digital Pill and Smartphone Support for PrEP
About this title
Read the official source — NCT03512418Medication studyAges 18+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- BoylstonSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: June 20, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Brigham and Women's Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Behavioural, Device, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT03512418
- Official title
Show the full official title
Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boylston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Brigham and Women's Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Truvada.
Who was this study for?
Listed age limits: from 18 years.
